(2015), interference with glycolytic metabolism—specifically inhibition of phosphoenolpyruvate (PEP) production—markedly impairs T cell receptor-induced calcium signaling and downstream NFAT-mediated transcription, ultimately diminishing the anti-tumor capability of CD8+ T cells (91, 113). This evidence concerns the gene CD8A and neoplasm.